We are live on ! Find out more
GCVRZ

Sanofi Contingent Value Rights

Delisted

GCVRZ was delisted on the 3rd of March, 2020.

146 hedge funds and large institutions have $324M invested in Sanofi Contingent Value Rights in 2013 Q2 according to their latest regulatory filings, with 146 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
146
Holders Change
+146
Holders Change %
% of All Funds
4.77%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.16%
New
146
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
FCM
26
Farallon Capital Management
California
$2.51M +$2.32M +1,320,000 New
PI
27
Putnam Investments
Massachusetts
$2.42M +$2.21M +1,255,462 New
UOC
28
UBS O'Connor
Illinois
$2.31M +$2.13M +1,215,025 New
BlackRock
29
BlackRock
New York
$2.28M +$2.11M +1,201,477 New
HA
30
Havens Advisors
New York
$2.07M +$1.91M +1,089,400 New
PCM
31
Pentwater Capital Management
Florida
$2.03M +$1.87M +1,066,977 New
Morgan Stanley
32
Morgan Stanley
New York
$1.93M +$1.79M +1,016,400 New
GI
33
GAMCO Investors
Connecticut
$1.82M +$1.68M +956,920 New
FCM
34
Freshford Capital Management
New York
$1.75M +$1.62M +923,206 New
Millennium Management
35
Millennium Management
New York
$1.74M +$1.61M +914,144 New
Bank of America
36
Bank of America
North Carolina
$1.69M +$1.56M +890,164 New
GCIA
37
Gabelli & Co Investment Advisers
New York
$1.64M +$1.52M +862,576 New
RFC
38
Russell Frank Company
Washington
$1.63M +$1.58M +900,000 New
BMO
39
Beck Mack & Oliver
New York
$1.38M +$1.28M +727,350 New
RP
40
Realm Partners
New York
$1.25M +$1.14M +650,473 New
Capstone Investment Advisors
41
Capstone Investment Advisors
New York
$1.22M +$1.11M +629,849 New
LCM
42
Lakewood Capital Management
New York
$1.18M +$1.09M +618,500 New
BIM
43
BlackRock Investment Management
Delaware
$1.04M +$958K +545,574 New
CPM
44
Chesapeake Partners Management
Maryland
$1.03M +$956K +544,000 New
HMC
45
Harbert Management Corporation
Alabama
$965K +$878K +500,000 New
ACM
46
Akanthos Capital Management
California
$950K +$878K +500,000 New
CCM
47
Contrarian Capital Management
Connecticut
$874K +$808K +460,188 New
LOM
48
Loeb Offshore Management
New York
$855K +$791K +450,000 New
PP
49
Paloma Partners
Connecticut
$801K +$729K +415,000 New
TL
50
TowerView LLC
New York
$585K +$541K +307,914 New

GCVRZ Hedge Fund Activity: Q2 2013 in Review

146 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q2 2013, worth a combined $324M.

Buyers outnumbered sellers: 146 funds opened new GCVRZ positions and 0 closed out — a net gain of 146 holders — while 0 added to existing stakes and 0 trimmed.

  • 146 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $324M of Sanofi Contingent Value Rights stock for Q2 2013.
  • 146 funds opened new Sanofi Contingent Value Rights positions in Q2 2013 and 0 closed out, a net change of +146 holders.

Based on aggregated 13F filings for Q2 2013.